• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓性肌萎缩症的表型修饰因子:SMN2基因拷贝数、NAIP基因缺失以及可能的性别会影响疾病进程。

Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease.

作者信息

Jedrzejowska Maria, Milewski Michał, Zimowski Janusz, Borkowska Janina, Kostera-Pruszczyk Anna, Sielska Danuta, Jurek Marta, Hausmanowa-Petrusewicz Irena

机构信息

Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warszawa, Poland.

出版信息

Acta Biochim Pol. 2009;56(1):103-8. Epub 2009 Mar 14.

PMID:19287802
Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations of the SMN1 gene. It is characterized by significant phenotype variability. In this study, we analyzed possible phenotype modifiers of the disease - the size of the deletion in the SMA region, the number of SMN2 gene copies, as well as the effect of gender. Among the factors analyzed, two seem to influence the SMA phenotype: the number of SMN2 gene copies and a deletion in the NAIP gene. A higher number of SMN2 copies makes the clinical symptoms more benign, and the NAIP gene deletion is associated with a more severe phenotype. The influence of gender remains unclear. In a group of 1039 patients, 55% of whom were male, the greatest disproportion was in the SMA1 (F/M = 0.78) and SMA3b (F/M = 0.45) forms. In SMA1 a deletion in the NAIP gene was seen twice as frequently in girls compared to boys. In three patients, we observed genotypes atypical for the chronic forms of SMA: two patients with SMA3a and 3b had a deletion of the NAIP gene, and a third patient with SMA2 had one copy of the SMN2 gene.

摘要

脊髓性肌萎缩症(SMA)是一种由SMN1基因突变引起的常染色体隐性神经肌肉疾病。其特征为显著的表型变异性。在本研究中,我们分析了该疾病可能的表型修饰因子——SMA区域缺失的大小、SMN2基因拷贝数以及性别的影响。在所分析的因素中,有两个因素似乎会影响SMA表型:SMN2基因拷贝数以及NAIP基因的缺失。SMN2拷贝数越多,临床症状越轻,而NAIP基因缺失与更严重的表型相关。性别的影响尚不清楚。在一组1039名患者中,其中55%为男性,最大的性别差异存在于SMA1型(女/男 = 0.78)和SMA3b型(女/男 = 0.45)。在SMA1型中,女孩中NAIP基因缺失的发生率是男孩的两倍。在三名患者中,我们观察到了慢性SMA形式的非典型基因型:两名SMA3a和3b型患者存在NAIP基因缺失,第三名SMA2型患者有一个SMN2基因拷贝。

相似文献

1
Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease.脊髓性肌萎缩症的表型修饰因子:SMN2基因拷贝数、NAIP基因缺失以及可能的性别会影响疾病进程。
Acta Biochim Pol. 2009;56(1):103-8. Epub 2009 Mar 14.
2
Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.SMN2基因拷贝数与NAIP基因缺失相结合可预测脊髓性肌萎缩症的疾病严重程度。
Brain Dev. 2009 Jan;31(1):42-5. doi: 10.1016/j.braindev.2008.08.012. Epub 2008 Oct 7.
3
Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.157 例中国脊髓性肌萎缩症患者的 SMN1、SMN2、NAIP、GTF2H2 和 H4F5 基因的分子分析。
Gene. 2013 Apr 15;518(2):325-9. doi: 10.1016/j.gene.2012.12.109. Epub 2013 Jan 23.
4
NAIP-deletion analysis in Malaysian patients with spinal muscular atrophy.马来西亚脊髓性肌萎缩症患者的NAIP基因缺失分析。
Kobe J Med Sci. 2007;53(4):171-5.
5
The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.40例脊髓性肌萎缩症患者生存运动神经元基因2和神经元凋亡抑制蛋白基因拷贝数与临床表型的相关性分析:观察性研究
Medicine (Baltimore). 2020 Jan;99(3):e18809. doi: 10.1097/MD.0000000000018809.
6
Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.沙特脊髓性肌萎缩症患者脊髓性肌萎缩症及神经元凋亡抑制蛋白基因的分子分析
Saudi Med J. 2003 Oct;24(10):1052-4.
7
SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.越南脊髓性肌萎缩症患者的SMN2和NAIP基因剂量
Pediatr Int. 2008 Jun;50(3):346-51. doi: 10.1111/j.1442-200X.2008.02590.x.
8
Molecular genetics of spinal muscular atrophy: contribution of the NAIP gene to clinical severity.脊髓性肌萎缩症的分子遗传学:NAIP基因对临床严重程度的影响。
Kobe J Med Sci. 2002 Apr;48(1-2):25-31.
9
Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.对携带单个SMN1基因拷贝的脊髓性肌萎缩症患者的SMN1基因点突变进行分析。
Neuromuscul Disord. 2007 Jun;17(6):476-81. doi: 10.1016/j.nmd.2007.03.003. Epub 2007 May 1.
10
High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.摩洛哥成年型脊髓性肌萎缩症患者中SMN1基因缺失的高发生率。
J Neurol. 2003 Oct;250(10):1209-13. doi: 10.1007/s00415-003-0186-1.

引用本文的文献

1
Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients.拷贝数与脊髓性肌萎缩严重程度的关联:来自哥伦比亚患者的见解
J Clin Med. 2024 Oct 25;13(21):6402. doi: 10.3390/jcm13216402.
2
Sexual dimorphisms in skeletal muscle: current concepts and research horizons.骨骼肌的性别二态性:当前概念和研究前沿。
J Appl Physiol (1985). 2024 Aug 1;137(2):274-299. doi: 10.1152/japplphysiol.00529.2023. Epub 2024 May 23.
3
RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.注册我:西班牙脊髓性肌萎缩症患者自我报告登记系统
Orphanet J Rare Dis. 2024 Feb 19;19(1):76. doi: 10.1186/s13023-024-03071-7.
4
Impaired Neurodevelopment in Children with 5q-SMA - 2 Years After Newborn Screening.5q-SMA 患儿的神经发育受损 - 新生儿筛查后 2 年。
J Neuromuscul Dis. 2024;11(1):143-151. doi: 10.3233/JND-230136.
5
Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients.印度尼西亚患者脊髓性肌萎缩症类型与延迟诊断的关系及脊柱畸形的风险。
Eur J Med Res. 2023 Mar 20;28(1):130. doi: 10.1186/s40001-023-01098-3.
6
A comprehensive overview of SMN and NAIP copy numbers in Iranian SMA patients.伊朗脊髓性肌萎缩症患者中生存运动神经元蛋白(SMN)和神经元凋亡抑制蛋白(NAIP)拷贝数的综合概述。
Sci Rep. 2023 Feb 24;13(1):3202. doi: 10.1038/s41598-023-30449-7.
7
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives.肌萎缩侧索硬化症和脊髓性肌萎缩症的基因治疗:进展、挑战与展望。
Int J Mol Sci. 2023 Jan 6;24(2):1130. doi: 10.3390/ijms24021130.
8
Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy.可变剪接在脊髓性肌萎缩症新疗法中的作用。
Genes (Basel). 2021 Aug 28;12(9):1346. doi: 10.3390/genes12091346.
9
Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.观察 3 型脊髓性肌萎缩症的自然病程:来自波兰脊髓性肌萎缩症登记处的数据。
Orphanet J Rare Dis. 2021 Mar 24;16(1):150. doi: 10.1186/s13023-021-01771-y.
10
In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.寻找治愈方法:改变脊髓性肌萎缩症进展的治疗方法的发展
Brain Sci. 2021 Feb 5;11(2):194. doi: 10.3390/brainsci11020194.